Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Modern Diagnostic & Research Centre Ltd (MDRC) Share Price & Fundamentals

Company Overview

Founded Year

1985

Listed Year

2026

Headquarter

-

MD/CEO

-

Website

-

Company Facts

What we do

Modern Diagnostic & Research Centre Ltd provides comprehensive diagnostic healthcare services including pathology and radiology through a network of 21 centers across 8 Indian states and some African countries.

Founded in

1,985

Market share

Known for affordable, integrated diagnostic solutions with a nationwide presence in India.

Problem solved

Addresses need for accessible, timely, and affordable diagnostic testing in healthcare.

Top clients or who we serve

Serves healthcare providers and patients across India and select African markets; B2C-focused diagnostic services.

Key management

-

Our journey and innovations

Started in 1985 as a proprietorship, converted to public limited in 2024, launched IPO in 2026; implemented PACS for digital image management.

Where we operate

India (majority revenue), Kenya, Nepal, Uganda, Tanzania, Ethiopia.

Top products or what we offer

Ultrasound, CT scan, MRI, Digital X-ray, Mammography, Heart Lab, Neuro Lab, ECG, and other advanced diagnostic tests.

Top brands

-

Raw materials needed

-

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily from recurring diagnostic test services.

Our industry position

Emerging diagnostic service provider with integrated offerings and expanding footprint in India.

Financial highlights

Revenue ₹77.95 crore, Net Profit ₹8.97 crore in FY 2024-25.

Geographical revenue split

India contributes 77% of revenue; balance from select African and Nepal markets.

Order book

-

Whats driving growth

Increasing demand for affordable diagnostics, expansion of centers, adoption of advanced technologies.

Our future plans

Expand diagnostic centers, invest in new technologies, and enhance digital healthcare solutions.

Our green promise

-

Our people and values

-

Key challenges ahead

Competition from large diagnostic chains and maintaining quality across regions.

Interesting facts

Pioneered integrated pathology and radiology services with advanced PACS system in its region.

Risks and strategy

Mitigating competitive risks by focusing on affordability, technology, and geographic expansion.

Market Footprint

Top Clients

Top Clients

Serves healthcare providers and patients across India and select African markets; B2C-focused diagnostic services.

Top Products

Top Products

Ultrasound, CT scan, MRI, Digital X-ray, Mammography, Heart Lab, Neuro Lab, ECG, and other advanced diagnostic tests.

Price Movement & Share Holding

Today's High/Low

5959.6

52 Week High/Low

45100
Past Returns

1 week

-5.3%

1 month

-15.3%

3 month

16.27%

1 year

-37.57%

3 year

-37.57%

5 year

-37.57%

Share Holding

Promoters

72.95%

FII

0%

DII

12.57%

Retail

9.11%

Others

5.37%

Company Overview

Founded Year

1985

Listed Year

2026

Headquarter

-

MD/CEO

-

Website

-

Price Movement & Share Holding

Today's High/Low

5959.6

52 Week High/Low

45100

Past Returns

1 week

-5.3%

1 month

-15.3%

3 month

16.27%

1 year

-37.57%

3 year

-37.57%

5 year

-37.57%

Share Holding

Promoters

72.95%

FII

0%

DII

12.57%

Retail

9.11%

Others

5.37%

Company Facts

What we do

Modern Diagnostic & Research Centre Ltd provides comprehensive diagnostic healthcare services including pathology and radiology through a network of 21 centers across 8 Indian states and some African countries.

Founded in

1985

Market share

Known for affordable, integrated diagnostic solutions with a nationwide presence in India.

Problem solved

Addresses need for accessible, timely, and affordable diagnostic testing in healthcare.

Top clients or who we serve

Serves healthcare providers and patients across India and select African markets; B2C-focused diagnostic services.

Our journey and innovations

Started in 1985 as a proprietorship, converted to public limited in 2024, launched IPO in 2026; implemented PACS for digital image management.

Where we operate

India (majority revenue), Kenya, Nepal, Uganda, Tanzania, Ethiopia.

Top products or what we offer

Ultrasound, CT scan, MRI, Digital X-ray, Mammography, Heart Lab, Neuro Lab, ECG, and other advanced diagnostic tests.

Recurring vs cyclical contribution

Revenue primarily from recurring diagnostic test services.

Our industry position

Emerging diagnostic service provider with integrated offerings and expanding footprint in India.

Financial highlights

Revenue ₹77.95 crore, Net Profit ₹8.97 crore in FY 2024-25.

Geographical revenue split

India contributes 77% of revenue; balance from select African and Nepal markets.

Whats driving growth

Increasing demand for affordable diagnostics, expansion of centers, adoption of advanced technologies.

Our future plans

Expand diagnostic centers, invest in new technologies, and enhance digital healthcare solutions.

Key challenges ahead

Competition from large diagnostic chains and maintaining quality across regions.

Interesting facts

Pioneered integrated pathology and radiology services with advanced PACS system in its region.

Risks and strategy

Mitigating competitive risks by focusing on affordability, technology, and geographic expansion.

Market Footprint

Top Clients

Top Clients

Serves healthcare providers and patients across India and select African markets; B2C-focused diagnostic services.

Top Products

Top Products

Ultrasound, CT scan, MRI, Digital X-ray, Mammography, Heart Lab, Neuro Lab, ECG, and other advanced diagnostic tests.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions